BML-PH(BML-PH)
$18.44—Stale · unknown old
BML-PH(BML-PH)
NYSE • Last print unknown ago
$18.44—Stale · unknown old
Q4 2026 EPS Estimate
$1.19
Oct 14, 2026 · Reports before open
Revenue Estimate
$31.35B
FY2026E EPS$4.64
FY2027E EPS$5.26
Analyst Sentiment
Wall St. Consensus
Hold32 analysts·High coverage
60
Score
15 Buy (47%)15 Hold (47%)2 Sell (6%)
Rating Breakdown
Strong Buy
00%
Buy
1547%
Hold
1547%
Sell
26%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$37.00
+100.7%
Consensus
$37.00
+100.7%
Bull
$37.00
+100.7%
12-Month Target Range32 analysts
$37.00$37.00$37.00
Current $18.44Consensus
Current Price
$18.44
Upside to Consensus
$18.56
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.19%
EPS+13.27%
FY2028
Rev+4.48%
EPS+11.88%
FY2029
Rev-2.17%
EPS+15.87%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $124.06B | $130.50B | $136.35B | $133.40B |
| Low | $122.84B | $128.76B | $134.77B | $131.85B |
| High | $126.36B | $134.12B | $139.52B | $136.50B |
| EBITDA Avg | $30.21B | $31.78B | $33.21B | $32.49B |
| Low | $29.92B | $31.36B | $32.82B | $32.11B |
| High | $30.77B | $32.66B | $33.98B | $33.24B |
| EBIT Avg | $28.41B | $29.88B | $31.22B | $30.54B |
| Low | $28.13B | $29.48B | $30.86B | $30.19B |
| High | $28.93B | $30.71B | $31.95B | $31.25B |
| Net Income Avg | $35.68B | $40.41B | $45.21B | $52.38B |
| Low | $35.14B | $39.80B | $44.53B | $51.59B |
| High | $36.75B | $41.63B | $46.58B | $53.97B |
| EPS Avg | $4.64 | $5.26 | $5.89 | $6.82 |
| Low | $4.57 | $5.18 | $5.80 | $6.72 |
| High | $4.79 | $5.42 | $6.06 | $7.03 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 5 / 1 | 10 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $31.35B | $30.80B | $32.23B | $32.84B | $32.82B | $32.45B | $34.08B | $33.99B |
| Low | $30.99B | $30.19B | $31.73B | $32.33B | $32.30B | $31.94B | $33.54B | $33.45B |
| High | $32.09B | $31.42B | $32.94B | $33.56B | $33.53B | $33.16B | $34.83B | $34.73B |
| EBITDA Avg | $7.63B | $7.50B | $7.85B | $8.00B | $7.99B | $7.90B | $8.30B | $8.28B |
| Low | $7.55B | $7.35B | $7.73B | $7.87B | $7.87B | $7.78B | $8.17B | $8.15B |
| High | $7.81B | $7.65B | $8.02B | $8.17B | $8.17B | $8.08B | $8.48B | $8.46B |
| EBIT Avg | $7.18B | $7.05B | $7.38B | $7.52B | $7.51B | $7.43B | $7.80B | $7.78B |
| Low | $7.09B | $6.91B | $7.26B | $7.40B | $7.40B | $7.31B | $7.68B | $7.66B |
| High | $7.35B | $7.20B | $7.54B | $7.68B | $7.68B | $7.59B | $7.97B | $7.95B |
| Net Income Avg | $8.69B | $8.48B | $8.98B | $9.77B | $9.98B | $9.82B | $10.16B | $10.73B |
| Low | $8.51B | $8.30B | $8.79B | $9.57B | $9.78B | $9.62B | $9.95B | $10.51B |
| High | $8.94B | $8.72B | $9.23B | $10.05B | $10.27B | $10.10B | $10.45B | $11.04B |
| EPS Avg | $1.19 | $1.16 | $1.23 | $1.34 | $1.37 | $1.35 | $1.39 | $1.47 |
| Low | $1.17 | $1.14 | $1.21 | $1.31 | $1.34 | $1.32 | $1.36 | $1.44 |
| High | $1.23 | $1.20 | $1.27 | $1.38 | $1.41 | $1.39 | $1.43 | $1.51 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 7 / 1 | 4 / 1 | 4 / 1 | 7 / 1 | 7 / 1 | 3 / 1 |